STRENSIQ
STRENSIQ
Approved
DIN Number
02444615
Drug Class
Human
Market Date
Oct 20, 2015
Company
HC
Alexion Pharma GmbH
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02444615
AIG Number0157271001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
A16AB13 ASFOTASE ALFA
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification44:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
ASFOTASE ALFAActive
Strength: 40 MG / ML
Monograph: ASFOTASE ALFA